Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinoma.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 19732012)

Published in Thyroid on October 01, 2009

Authors

Douglas Van Nostrand1, Frank Atkins, Shari Moreau, Martha Aiken, Kanchan Kulkarni, Jingshu S Wu, Kenneth D Burman, Leonard Wartofsky

Author Affiliations

1: Division of Nuclear Medicine, Department of Medicine, Washington Hospital Center, Washington, District of Columbia 20010, USA. douglas.van.nostrand@medstar.net

Articles by these authors

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12

Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77

American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71

Thyroid Nodules. N Engl J Med (2015) 2.65

The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid (2009) 2.35

Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET. J Nucl Med (2012) 2.08

Acute bacterial suppurative thyroiditis: a clinical review and expert opinion. Thyroid (2010) 1.65

Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils. J Innate Immun (2013) 1.63

Salivary gland protection with sialagogues: a case study. Thyroid (2009) 1.56

(124)I positron emission tomography versus (131)I planar imaging in the identification of residual thyroid tissue and/or metastasis in patients who have well-differentiated thyroid cancer. Thyroid (2010) 1.54

Anaplastic thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.54

A 2011 survey of clinical practice patterns in the management of Graves' disease. J Clin Endocrinol Metab (2012) 1.43

Subclinical hyperthyroidism: controversies in management. Am Fam Physician (2002) 1.42

Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid (2004) 1.41

Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration? Arch Intern Med (2005) 1.39

The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am (2007) 1.28

Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab (2002) 1.24

Clinical review: Ectopic cervical thyroid carcinoma--review of the literature with illustrative case series. J Clin Endocrinol Metab (2011) 1.21

The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab (2004) 1.20

Akt1 contains a functional leucine-rich nuclear export sequence. Biochem Biophys Res Commun (2005) 1.15

Hypothyroidism. Endocrinol Metab Clin North Am (2007) 1.14

Myxedema coma. J Intensive Care Med (2007) 1.12

Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid (2007) 1.11

Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab (2012) 1.08

Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab (2013) 1.08

Thyroid emergencies. Med Clin North Am (2012) 1.08

The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid (2009) 1.07

Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab (2013) 1.05

Treatment with thyroid hormone. Endocr Rev (2014) 1.05

Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. Thyroid (2010) 1.03

Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol Head Neck Surg (2005) 1.02

Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? Clin Endocrinol (Oxf) (2011) 1.01

Standardization of hormonal assays for the 21st century. J Clin Endocrinol Metab (2010) 0.99

Radioiodine in the treatment of thyroid cancer. Endocrinol Metab Clin North Am (2007) 0.99

KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. J Clin Endocrinol Metab (2005) 0.98

Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (2005) 0.98

Perioperative management of patients with hypothyroidism. Endocrinol Metab Clin North Am (2003) 0.97

Measuring the impact of passenger restrictions on new teenage drivers. Accid Anal Prev (2005) 0.96

Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells. Endocr Relat Cancer (2012) 0.96

17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. J Clin Endocrinol Metab (2004) 0.95

Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid (2002) 0.93

Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome. Thyroid (2009) 0.92

Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid (2013) 0.91

Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells. Mol Carcinog (2004) 0.90

Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging. Clin Nucl Med (2009) 0.90

Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. Thyroid (2012) 0.90

Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid (2005) 0.90

Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis. Thyroid (2005) 0.90

Metastases of well-differentiated thyroid cancer to the gastrointestinal system. Thyroid (2010) 0.89

Age and the thyrotropin response to hypothyroxinemia. J Clin Endocrinol Metab (2010) 0.89

Thyroid disorders in pregnancy. Endocrinol Metab Clin North Am (2011) 0.87

Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. Thyroid (2014) 0.86

Single-dose T3 administration: kinetics and effects on biochemical and physiological parameters. Ther Drug Monit (2015) 0.86

Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes? AJR Am J Roentgenol (2002) 0.85

Current treatment modalities for spinal metastases secondary to thyroid carcinoma. Thyroid (2014) 0.85

Micropapillary thyroid cancer: should we aspirate all nodules regardless of size? J Clin Endocrinol Metab (2006) 0.84

Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab (2002) 0.84

Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered? Nucl Med Commun (2014) 0.83

Levothyroxine treatment in pregnancy: indications, efficacy, and therapeutic regimen. J Thyroid Res (2011) 0.83

Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking. Thyroid (2005) 0.83

The effect of medications on thyroid function tests. Med Clin North Am (2012) 0.83

Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer. J Clin Endocrinol Metab (2011) 0.83

Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice. Thyroid (2010) 0.82

A 2013 survey of clinical practice patterns in the management of primary hypothyroidism. J Clin Endocrinol Metab (2014) 0.82

Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab (2012) 0.82

Detectability of foci of radioiodine uptake in the thyroid bed and neck comparing pinhole with parallel-hole collimators. Nucl Med Commun (2011) 0.82

The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. J Endocrinol (2012) 0.80

Two cases of statin-induced myopathy caused by induced hypothyroidism. Endocr Pract (2008) 0.80

Clinical criteria for the diagnosis of thyroid storm. Thyroid (2012) 0.80

Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. Endocr Pract (2013) 0.80

Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)I scanning. J Clin Endocrinol Metab (2002) 0.79

Thyrotoxicosis-induced ventricular arrhythmias. Thyroid (2008) 0.79

Overt and 'subclinical' hypothyroidism in women. Obstet Gynecol Surv (2006) 0.79

Salivary gland malignancy and radioiodine therapy for thyroid cancer. Thyroid (2010) 0.78